Live from the NIH registry
Studies recruiting near Frisco right now
Top 25 of 1,841 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Dallas, Texas (25.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Nephrotex Research Group — Dallas, Texas (25.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prostate Cancer, Prostate Adenocarcinoma
Phase 2
Interventional 90 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (25.8 mi)
· Sponsor: University of Chicago
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Sarah Cannon Research Institute at Mary Crowley — Dallas, Texas (25.8 mi)
· Sponsor: Revolution Medicines, Inc.
PET/MR for Characterization of Renal Masses (RMs)
Renal Tumor, Renal Cell Carcinoma
N/A
Observational 97 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (25.8 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Medical City Dallas Hospital — Dallas, Texas (25.8 mi)
· Sponsor: National Cancer Institute (NCI)
Leadership Training Affect Physician Career Satisfaction
Leadership, Personality
N/A
Interventional 200 participants sought
Clinical Research Institute at Methodist Health System — Dallas, Texas (25.8 mi)
· Sponsor: Methodist Health System
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
Postural Orthostatic Tachycardia Syndrome
N/A
Observational 350 participants sought
UT Southwestern Medical Center — Dallas, Texas (25.8 mi)
· Sponsor: University of Texas Southwestern Medical Center
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
UT Southwestern Medical Center — Dallas, Texas (25.8 mi)
· Sponsor: Pacific Edge Limited
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
Texas Oncology — Dallas, Texas (25.8 mi)
· Sponsor: Acepodia Biotech, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology - DFW — Dallas, Texas (25.8 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Dallas, Texas (25.8 mi)
· Sponsor: Dren Bio
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
Children's Medical Center Dallas — Dallas, Texas (25.8 mi)
· Sponsor: Azafaros B.V.
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Modern Research Associates, PLLC — Dallas, Texas (25.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (18.7 mi)
· Sponsor: Biogen
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Dallas — Dallas, Texas (25.8 mi)
· Sponsor: RAI Services Company
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
University of Texas-Southwestern — Dallas, Texas (25.8 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Baylor Scott and White Research Institute (Adults only) — Dallas, Texas (25.8 mi)
· Sponsor: Pierre Fabre Medicament
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Physical Inactivity, Phosphate Overload
N/A
Interventional 124 participants sought
University of Texas Southwestern — Dallas, Texas (25.8 mi)
· Sponsor: University of Texas Southwestern Medical Center
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Paralysis; Quadriplegic, Quadraplegia
N/A
Interventional 2 participants sought
UT Southwestern Medical Center — Dallas, Texas (25.8 mi)
· Sponsor: Nader Pouratian
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (25.8 mi)
· Sponsor: OncoNano Medicine, Inc.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Dallas, Texas (25.8 mi)
· Sponsor: AstraZeneca
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
Patellar Dislocation, Recurrent, Patellar Dislocation
N/A
Observational 850 participants sought
Scottish Rite for Children — Dallas, Texas (25.8 mi)
· Sponsor: Hospital for Special Surgery, New York
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Dallas, TX — Dallas, Texas (25.8 mi)
· Sponsor: Mediar Therapeutics
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer
Phase 1
Interventional 572 participants sought
NEXT Dallas — Irving, Texas (24.8 mi)
· Sponsor: ArriVent BioPharma, Inc.